LATEST

• BUSINESS Sanwa Kagaku Says Kumamoto Plant Remains Shut, Drug Supplies Stable
  July 31, 2026

• REGULATORY Japan to Ease Olanzapine Diabetes Contraindication for Antiemetic Use
  July 31, 2026

• BUSINESS CapEx by 25 Drug Makers in Japan Up 50% Since 2022: Fuji Keizai
  July 31, 2026

• COLUMN Why Your Brain Wants You to Stay (Even When You Want to Go)
  July 31, 2026

• BUSINESS Astellas Expands AI Drug Discovery to TPDs, Engineered Proteins
  July 30, 2026

• BUSINESS Regeneron Japan Files First Dual-AAV Therapy for Genetic Hearing Loss
  July 30, 2026

• BUSINESS Shionogi’s Xocova Debuts in US for COVID-19 PEP
  July 30, 2026

• BUSINESS Some Drug Plants Halt Operations after Kumamoto Temblor, Supplies Unaffected
  July 30, 2026

• BUSINESS Leqembi Global Sales Rise to 29.3 Billion Yen in April-June: Eisai
  July 30, 2026

• REGULATORY Pipe Damage Causes Water Leak at Sawai Plant after Quake: MHLW
  July 30, 2026

• REGULATORY MHLW Urges Stable Supply of Drugs after Kumamoto Earthquake
  July 30, 2026

• REGULATORY Kumamoto Quake Hits 46 Medical Facilities; No Pharma Damage Yet: MHLW
  July 29, 2026

• BUSINESS MSD Urges Swift Rollout of Routine HPV Vaccination for Males in Japan
  July 29, 2026

• BUSINESS Drug Makers, Wholesalers Rush to Gauge Kumamoto Quake Impact
  July 29, 2026

• BUSINESS Takeda Files Entyvio IV for Pediatric Use, New Adult Dosing in Japan
  July 29, 2026

• REGULATORY Japan Shifts Mo-99 Supply Strategy toward Stronger Global Procurement: Panel
  July 29, 2026

• REGULATORY 3 Label Expansions Get NHI Coverage on Public Knowledge Pathway
  July 29, 2026

• BUSINESS Otsuka Ups 1H Guidance on Strong Sales, Delayed Generic Competition
  July 29, 2026

• REGULATORY No Cap on FY2027 Budget Requests under Growth Investment Scheme: MOF
  July 29, 2026

• BUSINESS Japan OTC Market Falls for 4th Straight Month in June: Intage
  July 29, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• …
• Next ›
• 最終 »